Dr. Souweidane’s Ongoing DIPG Trial Findings Published in Lancet Oncology
July 10, 2018 - The Lancet Oncology published the highly anticipated results of Dr. Mark Souweidane’s first-ever dose escalation study using convection-enhanced delivery (CED) in patients with DIPG. The proven safety of this direct drug delivery approach will open many doors for new treatment options.


